Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice

Hilda Martínez‐Coria(University of California, Irvine), Kim N. Green(MerLion Pharma (Germany)), Lauren M. Billings(MerLion Pharma (Germany)), Masashi Kitazawa(University of California, Irvine), Miriam Albrecht(MerLion Pharma (Germany)), Gerhard Rammes(Technical University of Munich), Chris G. Parsons(MerLion Pharma (Germany)), Sandeep Gupta, Pradeep Banerjee, Frank M. LaFerla(University of California, Irvine)
American Journal Of Pathology
December 30, 2009
10.2353/ajpath.2010.090452
Cited by 215Open Access
Full Text

Abstract

Related Papers

Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
Salvatore Oddo, Antonella Caccamo, Jason D. Shepherd et al.|Neuron|2003|4.1k
Cholinesterase inhibitors for Alzheimer's disease
Jacqueline Birks|Cochrane Database of Systematic Reviews|2006|1.9k
Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway
Ganesh M. Shankar, Brenda L. Bloodgood, Matthew Townsend et al.|Journal of Neuroscience|2007|1.6k
Regulation of NMDA receptor trafficking by amyloid-β
Eric M. Snyder, Yi Nong, Cláudia G. Almeida et al.|Nature Neuroscience|2005|1.5k
Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice
Lauren M. Billings, Salvatore Oddo, Kim N. Green et al.|Neuron|2005|1.3k